An open-label phase II study of low-dose thalidomide in androgen-independent prostate cancer.

Autor: Drake, M J, Robson, W, Mehta, P, Schofield, I, Neal, D E, Leung, H Y
Zdroj: British Journal of Cancer. 3/24/2003, Vol. 88 Issue 6, p822. 6p.
Databáze: Academic Search Ultimate